- Home
- FBK vs VCEL Comparison
FBK vs VCEL Comparison
Compare FBK & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- VCEL
- Stock Information
- Founded
- FBK 1906
- VCEL 1989
- Country
- FBK United States
- VCEL United States
- Employees
- FBK N/A
- VCEL N/A
- Industry
- FBK Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBK Finance
- VCEL Health Care
- Exchange
- FBK Nasdaq
- VCEL Nasdaq
- Market Cap
- FBK 2.1B
- VCEL 2.1B
- IPO Year
- FBK 2016
- VCEL 1997
- Fundamental
- Price
- FBK $53.15
- VCEL $30.45
- Analyst Decision
- FBK Buy
- VCEL Strong Buy
- Analyst Count
- FBK 5
- VCEL 6
- Target Price
- FBK $59.00
- VCEL $61.50
- AVG Volume (30 Days)
- FBK 297.5K
- VCEL 729.6K
- Earning Date
- FBK 10-14-2025
- VCEL 11-06-2025
- Dividend Yield
- FBK 1.45%
- VCEL N/A
- EPS Growth
- FBK N/A
- VCEL 2045.40
- EPS
- FBK 1.94
- VCEL 0.13
- Revenue
- FBK $410,807,000.00
- VCEL $249,119,000.00
- Revenue This Year
- FBK $35.00
- VCEL $18.35
- Revenue Next Year
- FBK $21.58
- VCEL $22.47
- P/E Ratio
- FBK $26.97
- VCEL $243.20
- Revenue Growth
- FBK N/A
- VCEL 16.13
- 52 Week Low
- FBK $38.83
- VCEL $30.26
- 52 Week High
- FBK $58.88
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- FBK 57.79
- VCEL 50.41
- Support Level
- FBK $51.62
- VCEL $30.26
- Resistance Level
- FBK $53.50
- VCEL $33.92
- Average True Range (ATR)
- FBK 1.01
- VCEL 1.42
- MACD
- FBK -0.27
- VCEL -1.92
- Stochastic Oscillator
- FBK 44.72
- VCEL 83.62
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.